Longterm Favorable Results of Limited Hepatic Resections for Patients with Hepatocellular Carcinoma: 20 Years of Experience
Yo‐ichi Yamashita(Kumamoto University), Yoshihiko Maehara(Kyushu University), Norifumi Harimoto(National Kyushu Medical Center), Dai Kitagawa(Kyushu University), Hiroto Kayashima(Kyushu University), Eiji Tsujita(Kyushu University), Akinobu Taketomi(Hokkaido University), Yosuke Kuroda(National Agriculture and Food Research Organization), Shinji Itoh(Kyushu University)
Cited by 133
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244